Shop Feast →
After your meal

Curcumin Phytosome

120mg per serving

Anti-inflammatory curcumin with 29x better absorption via phospholipid delivery.

Curcumin Phytosome

Overview

What it is

Curcumin phytosome is curcumin complexed with sunflower-derived phosphatidylcholine using Indena's Meriva technology. Standard curcumin has notoriously poor bioavailability — less than 1% reaches systemic circulation when taken orally. The phytosome formulation wraps curcumin in a phospholipid membrane, dramatically improving intestinal absorption. The 120mg dose delivers approximately 42mg of active curcumin at up to 29x the bioavailability of unformulated curcumin.

Mechanism

How it works

Once released in the intestines, the phospholipid carrier integrates with the intestinal cell membranes, shuttling curcumin across the gut barrier and into circulation. In the GI tract, curcumin inhibits NF-kB signaling — the master inflammatory pathway — reducing the production of pro-inflammatory cytokines (TNF-alpha, IL-1beta, IL-6) that contribute to post-meal intestinal inflammation. It also modulates COX-2 activity, reducing prostaglandin-mediated inflammation in the gut wall.

Why it helps

Key benefits

Reduces post-meal intestinal inflammation via NF-kB inhibition

Delivers 29x better curcumin absorption than standard formulations

Modulates inflammatory cytokines in the GI tract

Supports long-term digestive tissue health with daily use

Evidence

The research

Comparative absorption of a standardized curcuminoid mixture and its lecithin formulation

Cuomo J, Appendino G, Dern AS, et al. · Journal of Natural Products (2011)

Curcumin phytosome (Meriva® technology) demonstrated 29-fold higher plasma curcumin absorption compared to unformulated curcumin in a crossover pharmacokinetic study, validating the phospholipid delivery system.

Curcumin supplementation (Meriva®) modulates inflammation, lipid peroxidation and gut microbiota composition in chronic kidney disease

Pivari F, Di Perna A, Giordano M, et al. · Nutrients (2022)

In a pilot study of 24 CKD patients, Meriva® curcumin for 6 months significantly reduced plasma inflammatory markers (CCL-2, IFN-γ, IL-4) and lipid peroxidation, while increasing beneficial Lactobacillaceae gut bacteria.

Efficacy and safety of Meriva® during extended administration in osteoarthritis patients

Belcaro G, Cesarone MR, Dugall M, et al. · Alternative Medicine Review (2010)

In a 3-month clinical trial, 200mg curcuminoids from Meriva® maintained healthy CRP levels and significantly reduced inflammatory markers, confirming systemic anti-inflammatory activity with a favorable safety profile. Meriva has been studied in 35+ clinical trials.

Dosage

120mg per serving

Why this dose

The 120mg curcumin phytosome dose matches the amount used in the clinical trial combining curcumin phytosome with fennel seed oil for IBS symptom management. At 29x standard bioavailability, this delivers curcumin exposure equivalent to roughly 3,500mg of unformulated curcumin — well within the therapeutic range without the need for piperine.

Safety & tolerability

Curcumin phytosome is well-tolerated. Unlike standard curcumin supplements, this formulation does not require piperine (black pepper extract) for absorption, avoiding the drug interaction concerns associated with piperine's inhibition of hepatic enzymes.

The formula

Why it matters

Heavy meals trigger a low-grade inflammatory response in the intestines as the immune system reacts to incoming food particles, bacterial endotoxins, and oxidized fats. This inflammation contributes to the sluggishness and discomfort that follow rich meals. Curcumin phytosome dampens this response, supporting faster digestive recovery. Its pairing with fennel seed oil follows the exact protocol used in published clinical trials.

19 ingredients, full transparency

Every ingredient, every dose, fully disclosed.